NCT06519604View on ClinicalTrials.gov

Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 17, 2024

Primary Completion Date

September 13, 2024

Study Completion Date

October 30, 2025

Conditions
Diabete Mellitus
Interventions
DRUG

Human insulin enteric coated capsules in dose 16mg

Single oral administration of human insulin enteric coated capsules in dose 16mg

DRUG

Human insulin enteric coated capsules in dose 8mg

Single oral administration of human insulin enteric coated capsules in dose 16mg

DRUG

Human Insulin Injection in dose 5IU

Single subcutaneous administration of Human Insulin Injection in dose 5IU

Trial Locations (1)

200025

uijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT06519604 - Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males | Biotech Hunter | Biotech Hunter